Abstract
A fragment-based development of 3C-triazol-1-yl-O-galactopyranosyl aldoximes led to the discovery of highly selective and high affinity (K(d) down to 11 microm) small monosaccharide based inhibitors of galectin-3. Galectin-7, 8 N-terminal CRD, and 9 N-terminal CRD bound the inhibitors only weakly. The galectin-3 selectivity was hypothesized to stem from interaction of the aldoxime moiety with a site not present in the other galectins.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acylation
-
Binding Sites
-
Drug Discovery
-
Galectin 3 / antagonists & inhibitors
-
Galectin 3 / chemistry
-
Galectin 3 / metabolism*
-
Hydroxylamines / chemistry
-
Models, Molecular
-
Molecular Conformation
-
Oxidation-Reduction
-
Oximes / chemical synthesis
-
Oximes / chemistry*
-
Oximes / metabolism*
-
Oximes / pharmacology
-
Protein Binding
-
Protein Structure, Tertiary
-
Substrate Specificity
-
Triazoles / chemistry*
Substances
-
Galectin 3
-
Hydroxylamines
-
Oximes
-
Triazoles